(BPRW) Vermillion, Inc. and Einstein Medical Center Philadelphia Announce the First Patient Enrolled in Prospective National Clinical Study of Ovarian Cancer Risk Detection Methods in African American Women



(Black PR Wire) AUSTIN, Texas & PHILADELPHIA–(BUSINESS WIRE)– Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease and Einstein Medical Center, the largest independent academic



Source link

Follow by Email
Facebook
Facebook
Instagram